Table 6.
Summary of PASS measurements for the anti-viral activity of Melissa officinalis isolated phytoconstituents.
| Main predicted activity by PASS online | Luteolin-7-glucoside-3′-glucuronide | Melitric acid A | Quadranoside III | |||
|---|---|---|---|---|---|---|
| Pa | Pi | Pa | Pi | Pa | Pi | |
| Antiviral (Rhinovirus) | – | – | 0.348 | 0.162 | 0.410 | 0.081 |
| Antiviral (HIV) | 0.140 | 0.078 | 0.299 | 0.008 | 0.126 | 0.101 |
| Antiviral (Influenza) | 0.773 | 0.003 | 0.262 | 0.120 | 0.802 | 0.003 |
| Antiviral (Herpes) | 0.486 | 0.011 | 0.244 | 0.135 | 0.724 | 0.003 |
| Antiviral (Hepatitis B) | 0..463 | 0.007 | 0.222 | 0.067 | 0.300 | 0.033 |
| Antiviral (Trachoma) | 0.090 | 0.055 | – | – | – | – |
| Viral Entry Inhibitor | – | – | 0.205 | 0.138 | - | – |
Note: PASS = Prediction of Activity Spectra for Substances; Pi = probable inactivity.